Human Milk Oligosaccharides (HMO) Market Report 2019-2029

人乳オリゴ糖(HMO)の世界市場2019-2029

◆タイトル:Human Milk Oligosaccharides (HMO) Market Report 2019-2029
◆商品コード:VGN910309
◆調査・発行会社:visiongain
◆発行日:2019年8月2日
◆ページ数:159
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:食品
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥468,866見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥522,466見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥669,866見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"人乳オリゴ糖(HMO)の世界市場2019-2029"について調査・分析し、レポートサマリー、市場の促進要因、抑制要因、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、用途別分析、市場シェア分析、市場環境分析、主要企業分析、結論、提言などの情報をお届けいたします。

• Do you need definitive Human Milk Oligosaccharides (HMO) Market data?• Succinct Human Milk Oligosaccharides (HMO) Market analysis?
• Clear competitor analysis?
• Actionable business recommendations?
In particular, Human Milk Oligosaccharides report concentrates on the following essential aspects of the Human Milk Oligosaccharides industry:
• Analysis of Key Players in Human Milk Oligosaccharides
• Inbiose NV
• Elicityl S.A.
• Jennewein Biotechnologie GmbH
• Glycom A/S
• Medolac Laboratories
• ZuChem Inc.
• Glycosyn LLC
• Gnubiotics Sciences Sarl
Global Human Milk Oligosaccharides (HMO) Market Outlook and Analysis from 2019-2029
• Human Milk Oligosaccharides (HMO) Market Forecasts and Analysis from 2019-2029 by Application
• Infant Formula Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Functional Food & Beverages Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Food Supplements Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Others Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Human Milk Oligosaccharides (HMO) Market Forecasts and Analysis from 2019-2029 by Product Type
• 2’FL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• 3’FL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• 3’SL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• 6’SL Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Other Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Regional and Leading National Human Milk Oligosaccharides (HMO) Market Forecasts and Analysis from 2019-2029
• North America Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• US Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Canada Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Mexico Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Europe Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Germany Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• UK Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• France Human Milk Oligosaccharides (HMO) Forecast 2019 – 2029
• Italy Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Russia Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of Europe Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Asia-Pacific Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• China Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Japan Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• India Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of Asia-Pacific Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Latin America Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Brazil Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of Latin America Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• MEA Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Israel Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Saudi Arabia Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• South Africa Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• UAE Human Milk Oligosaccharides (HMO) Forecast 2019-2029
• Rest of MEA Human Milk Oligosaccharides (HMO) Forecast 2019-2029
The Global Human Milk Oligosaccharides (HMO) Market 2019-2029 examines the Human Milk Oligosaccharides (HMO) Market comprehensively, using unique primary and secondary research all available to you, now.
Exclusively, Visiongain have applied our in-house analytical techniques for financial forecasting and analysis of drivers and restraints. Now available to you this comprehensive market-based report with detailed analyses, forecasts and informed opinion is essential to your Human Milk Oligosaccharides (HMO) Market development.
Human Milk Oligosaccharides (HMO) differ from currently-marketed Human Milk Oligosaccharides (HMO)s. Visiongain predicts that Human Milk Oligosaccharides (HMO) will significantly expand at a very high rate, contributing to rapid revenue growth during the period 2019 to 2028.
Why you should buy this report:
• To receive a comprehensive analysis of the prospects for Human Milk Oligosaccharides (HMO)
• To receive forecasts of Human Milk Oligosaccharides (HMO) sales in leading country markets from 2019-2029, including China, Japan and India
• To determine the forces that influence the market for Human Milk Oligosaccharides (HMO): drivers, restraints, opportunities and threats
• To find out where the Human Milk Oligosaccharides (HMO) Market is heading – both technologically and commercially from 2019-2029
Why You Must Buy This Report:
This report features news, insights, the latest developments and an in-depth survey of the Human Milk Oligosaccharides (HMO) Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors. You cannot afford to be without this latest report from Visiongain.

【レポートの目次】

1. Report Overview
1.1 Global Human Milk Oligosaccharides (HMO) Market Overview
1.2 Global Human Milk Oligosaccharides (HMO) Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Secondary Research
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to the Human Milk Oligosaccharides (HMO) Market
2.1 Global Human Milk Oligosaccharides (HMO) Market Structure
2.2 Human Milk Oligosaccharides (HMO) Market Definition
2.3 Human Milk Oligosaccharides (HMO) Market Supply Chain

3. Global Human Milk Oligosaccharides (HMO) Market 2019-2029
3.1 Global Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
3.2 Global Human Milk Oligosaccharides (HMO) Market Analysis
3.3 Global Human Milk Oligosaccharides (HMO) Market Drivers & Restraints 2019

4. Global Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029
4.1 Global Human Milk Oligosaccharides (HMO) Market Forecast by Antibiotics Segment 2019-2029
4.2 Global Human Milk Oligosaccharides (HMO) Market Forecast by 2’FL Segment 2019-2029
4.3 Global Human Milk Oligosaccharides (HMO) Market Forecast by 3’FL Segment 2019-2029
4.4 Global Human Milk Oligosaccharides (HMO) Market Forecast by 6’SL Segment 2019-2029

5. Global Human Milk Oligosaccharides (HMO) Market Forecast by Application 2019-2029
5.1 Global Human Milk Oligosaccharides (HMO) Market Forecast by Functional Food & Beverage Segment 2019-2029
5.2 Global Human Milk Oligosaccharides (HMO) Market Forecast by Infant Formula Segment 2019-2029
5.3 Global Human Milk Oligosaccharides (HMO) Market Forecast by Food Supplements Segment 2019-2029
5.4 Global Human Milk Oligosaccharides (HMO) Market Forecast by Processed Food Segment 2019-2029

6. Regional and Leading National Human Milk Oligosaccharides (HMO) Market Forecasts 2019-2029
6.1 North American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029
6.1.2 North America Human Milk Oligosaccharides (HMO) Market by Application 2019-2029
6.1.4 North America Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.1.5 North American Human Milk Oligosaccharides (HMO) Market Analysis
6.2 Asia Pacific Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
6.2.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.2.3 Asia Pacific Human Milk Oligosaccharides (HMO) Market Analysis
6.3 Europe Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
6.3.2 European Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.3.3 European Human Milk Oligosaccharides (HMO) Market Analysis
6.4 Latin American Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029
6.4.2 Latin America Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.5 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029
6.5.2 MEA Human Milk Oligosaccharides (HMO) Market by Country 2019-2029
6.6 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2019, 2024 and 2029

7. SWOT Analysis of the Human Milk Oligosaccharides (HMO) Market 2019-2029

8. Leading Companies in the Human Milk Oligosaccharides (HMO) Market 2019
8.1 Leading Human Milk Oligosaccharides (HMO) Companies 2019
8.2 Inbiose NV
8.2.1 Inbiose NV Human Milk Oligosaccharides (HMO) Selected Recent Key Developments 2014-2018
8.2.2 Inbiose NV Sales 2015-2018
8.2.3 Inbiose NV Net Income 2015-2018
8.2.4 Inbiose NV Business Divisions
8.2.5 Inbiose NV Human Milk Oligosaccharides (HMO) Market Products / Services
8.2.6 Inbiose NV Overview
8.2.7 Inbiose NV Financial Outlook
8.2.8 Inbiose NV SWOT Analysis
8.3 Elicityl S.A.
8.3.1 Elicityl S.A. Key Development
8.3.2 Elicityl S.A. Sales 2014-2018
8.3.3 Elicityl S.A. Net Income / Loss 2014-2018
8.3.4 Elicityl S.A. Organisational Structure
8.3.5 Elicityl S.A. Human Milk Oligosaccharides (HMO) Products / Services
8.3.6 Elicityl S.A. Overview
8.3.7 Elicityl S.A. Financial Outlook
8.3.8 Elicityl S.A. SWOT Analysis
8.4 Jennewein Biotechnologie GmbH
8.4.1 Jennewein Biotechnologie GmbH Human Milk Oligosaccharides (HMO) Key Developments 2014-2017
8.4.2 Jennewein Biotechnologie GmbH Sales 2014-2018
8.4.3 Jennewein Biotechnologie GmbH Net Income 2014-2018
8.4.4 Jennewein Biotechnologie GmbH Organisational Structure
8.4.5 Jennewein Biotechnologie GmbH Human Milk Oligosaccharides (HMO) Market Products / Services
8.4.6 Jennewein Biotechnologie GmbH Overview
8.4.7 Jennewein Biotechnologie GmbH Financial Outlook
8.4.8 Jennewein Biotechnologie GmbH SWOT Analysis
8.5 Glycom A/S
8.5.1 Glycom A/S Human Milk Oligosaccharides (HMO) Key Developments 2017-2018
8.5.2 Glycom A/S Sales 2014-2018
8.5.3 Glycom A/S Net Income 2014-2018
8.5.4 Glycom A/S Company Structure
8.5.5 Glycom A/S Human Milk Oligosaccharides (HMO) Market Products / Services
8.5.6 Glycom A/S Overview
8.5.7 Glycom A/S Financial Outlook
8.5.8 Glycom A/S SWOT Analysis
8.6 Medolac Laboratories ‏
8.6.1 Medolac Laboratories Key Developments 2015-2018
8.6.2 Medolac Laboratories Sales 2015-2018
8.6.3 Medolac Laboratories Net Income 2015-2018
8.6.4 Medolac Laboratories Business Sectors
8.6.5 Medolac Laboratories Human Milk Oligosaccharides (HMO) Market Products / Services
8.6.6 Medolac Laboratories Overview
8.6.7 Medolac Laboratories Financial Outlook
8.6.8 Medolac Laboratories SWOT Analysis
8.7 ZuChem Inc.
8.7.1 ZuChem Inc. Key Developments 2015-2018
8.7.2 ZuChem Inc. Human Milk Oligosaccharides (HMO) Market Products / Services
8.7.3 ZuChem Inc. Financial Outlook
8.8 Glycosyn LLC
8.8.1 Glycosyn LLC Key Developments 2016-2017
8.8.2 Glycosyn LLC Sales 2015-2018
8.8.3 Glycosyn LLC Company Structure
8.8.4 Glycosyn LLC Human Milk Oligosaccharides (HMO) Market Products / Services
8.8.5 Glycosyn LLC Overview.
8.8.6 Glycosyn LLC Financial Outlook
8.9 Gnubiotics Sciences Sarl
8.8.1 Gnubiotics Sciences Sarl Key Developments
8.8.2 Gnubiotics Sciences Sarl Sales 2014-2018
8.8.3 Gnubiotics Sciences Sarl Net Income / Loss 2014-2018
8.8.4 Gnubiotics Sciences Sarl Overview
8.8.5 Gnubiotics Sciences Sarl Financial Outlook
8.9 Other Leading Companies in the Value Chain

10. Conclusions
10.1 Key Research finding
10.2 Conclusion by Geography
10.2 Conclusion by Product Type
10.3 Conclusion by Application
10.4 Strategic Recommendations

11. Glossary

Associated Visiongain Reports
Visiongain Report Sales Order
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form

List of Figures
Figure 1.1 Global Human Milk Oligosaccharides (HMO) Market Segmentation
Figure 2.1 Global Human Milk Oligosaccharides (HMO) Market Segmentation Overview
Figure 2.2 Global Human Milk Oligosaccharides (HMO) Market Supply Chain
Figure 3.1 Global Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$m, AGR %)
Figure 4.1 Global Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 4.2 Global Human Milk Oligosaccharides (HMO) Market Forecast for the Antibiotics Segment by Region 2019, 2024, 2029 (% Share)
Figure 4.3 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 2’FL Segment by Region 2019, 2024, 2029 (% Share)
Figure 4.4 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 3’FL Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.2 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for 3’FL Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.3 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for 3’SL Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.4 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for Feed Acidifiers Segment by Region 2019, 2024, 2029 (% Share)
Figure 5.5 Global Human Milk Oligosaccharides (HMO) Market Share Forecast for Others Segment by Region 2019-2024-2029 (%)
Figure 6.1 Regional Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$m, AGR%)
Figure 6.2 North American Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.3 North American Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$m, AGR%)
Figure 6.6 North America Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.7 North America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.8 US Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.9 Canada Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.10 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.11 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.14 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.15 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.16 China Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.17 India Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.18 Japan Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.19 Europe Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.20 European Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.23 European Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.24 European Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.25 Germany Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.26 UK Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.27 France Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.28 Italy Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.29 Russia Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.30 Latin American Human Milk Oligosaccharides (HMO) Market Share Forecast 2019, 2024, 2029 (% Share)
Figure 6.31 Latin American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.34 Latin America Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.35 Latin America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.36 Brazil Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.37 MEA Human Milk Oligosaccharides (HMO) Market Share Forecast by Product Type 2019, 2024, 2029 (% Share)
Figure 6.38 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$m, AGR%)
Figure 6.41 MEA Human Milk Oligosaccharides (HMO) Market Share Forecast by Country 2019, 2024, 2029 (% Share)
Figure 6.42 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.43 Israel Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.44 Saudi Arabia Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.45 South Africa Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.46 UAE Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.47 Rest of MEA Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$m, AGR%)
Figure 6.48 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2019 (% Share)
Figure 6.49 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2024 (% Share)
Figure 6.50 Regional Human Milk Oligosaccharides (HMO) Market Share Forecast 2029 (% Share)
Figure 8.1 Inbiose NV Sales 2015-2018 (US$m, AGR %)
Figure 8.2 Inbiose NV Net Income 2015-2018 (US$m, AGR %)
Figure 8.3 Inbiose NV Business Divisions 2017
Figure 8.4 Elicityl S.A. Sales 2014-2018 (US$m, AGR %)
Figure 8.5 Elicityl S.A. Net Income / Loss 2014-2018 (US$m)
Figure 8.6 Elicityl S.A. Organisational Structure 2017
Figure 8.7 Elicityl S.A. Segment Performance 2018 (%)
Figure 8.8 Jennewein Biotechnologie GmbH Sales 2014-2018 (US$m, AGR %)
Figure 8.9 Jennewein Biotechnologie GmbH Net Income 2014-2018 (US$m, AGR %)
Figure 8.10 Jennewein Biotechnologie GmbH Organisational Structure 2018
Figure 8.11 Glycom A/S Sales 2014-2018 (US$m, AGR %)
Figure 8.12 Glycom A/S Net Income 2014-2018 (US$m)
Figure 8.13 Glycom A/S Company Structure 2019
Figure 8.14 Medolac Laboratories Sales 2015-2018 (US$m, AGR %)
Figure 8.15 Medolac Laboratories Net Income 2015-2018 (US$m)
Figure 8.16 Medolac Laboratories Business Sectors 2018
Figure 8.17 Glycosyn LLC Sales 2015-2018 (US$m, AGR %)
Figure 8.18 Glycosyn LLC Company Structure 2018
Figure 8.19 Gnubiotics Sciences Sarl Sales 2013-2017 (US$m, AGR %)
Figure 8.20 Gnubiotics Sciences Sarl Net Income / Loss 2014-2018 (US$m)
Figure 8.21 Gnubiotics Sciences Sarl Segment Performance 2018 (%)
Figure 8.22 Agrana Beteiligungs-AG Sales 2013-2017 (US$m, AGR %)
Figure 8.23 Agrana Beteiligungs-AG Industry Group Revenue Share 2017 (%)
Figure 8.24 Agrana Beteiligungs-AG Products Segment Information 2018

List of Tables
Table 3.1 Global Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.1 Global Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.2 Global Human Milk Oligosaccharides (HMO) Market Forecast for the Antibiotics Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.3 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 2’FL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 4.4 Global Human Milk Oligosaccharides (HMO) Market Forecast for the 3’FL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.2 Global Human Milk Oligosaccharides (HMO) Market Forecast for 3’FL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.3 Global Human Milk Oligosaccharides (HMO) Forecast for the 3’SL Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.4 Global Human Milk Oligosaccharides (HMO) Market Forecast for Feed Acidifiers Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 5.5 Global Human Milk Oligosaccharides (HMO) Market Forecast for Others Segment by Region 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.1 Regional Human Milk Oligosaccharides (HMO) Market Forecast 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.2 North American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.4 North America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.5 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.7 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.8 Europe Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.10 European Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.11 Latin American Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.13 Latin America Human Milk Oligosaccharides (HMO) Market Forecast by Country 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 6.14 MEA Human Milk Oligosaccharides (HMO) Market Forecast by Product Type 2019-2029 (US$Mn, AGR%, CAGR %, Cumulative)
Table 7.1 Global Human Milk Oligosaccharides (HMO) Market SWOT Analysis 2019-2029
Table 8.1 Leading Human Milk Oligosaccharides (HMO) Companies 2019 (S.No., Company Name)
Table 8.2 Inbiose NV Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.3 Inbiose NV Key Developments 2014-2018 (Date, Strategy, Details)
Table 8.4 Inbiose NV Sales 2015-2018 (US$m, AGR %)
Table 8.5 Inbiose NV Net Income 2015-2018 (US$m, AGR %)
Table 8.6 Inbiose NV Human Milk Oligosaccharides (HMO) Market Products/Services (Segment of Business, Product, Specification / Features)
Table 8.7 Inbiose NV SWOT Analysis 2018
Table 8.8 Elicityl S.A. Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, No. of employees, Website)
Table 8.9 Elicityl S.A. Key Development (Date, Strategy, Details)
Table 8.10 Elicityl S.A. Sales 2014-2018 (US$m, AGR %)
Table 8.11 Elicityl S.A. Net Income / Loss 2014-2018 (US$MN)
Table 8.12 Elicityl S.A. Human Milk Oligosaccharides (HMO) Products/Services (Segment of Business, Product, Specification/ Features)
Table 8.13 Elicityl S.A. SWOT Analysis 2018
Table 8.14 Jennewein Biotechnologie GmbH Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, Website)
Table 8.15 Jennewein Biotechnologie GmbH Key Developments (Date, Strategy, Details)
Table 8.16 Jennewein Biotechnologie GmbH Sales 2014-2018 (US$m, AGR %)
Table 8.17 Jennewein Biotechnologie GmbH Net Income 2014-2018 (US$m, AGR %)
Table 8.18 Jennewein Biotechnologie GmbH Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.19 Jennewein Biotechnologie GmbH SWOT Analysis 2018
Table 8.20 Glycom A/S Profile 2019 (CEO, Parent Company Sales US$m, Net Income, HQ, Founded, No. of Employees, Website)
Table 8.21 Glycom A/S Key Developments 2017-2018 (Date, Strategy, Details)
Table 8.22 Glycom A/S Sales 2014-2018 (US$m, AGR %)
Table 8.23 Glycom A/S Net Income 2014-2018 (US$m)
Table 8.24 Glycom A/S Human Milk Oligosaccharides (HMO) Market Products/Services (Segment of Business, Product, Specification / Features)
Table 8.25 Glycom A/S SWOT Analysis 2018
Table 8.26 Medolac Laboratories Profile 2019 (CEO, Parent Company Sales US$m, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.27 Selected Recent Medolac Laboratories Human Milk Oligosaccharides (HMO) Market Developments 2015-2018 (Date, Strategy, Details)
Table 8.28 Medolac Laboratories Sales 2015-2018 (US$m, AGR %)
Table 8.29 Medolac Laboratories Net Income 2015-2018 (US$m, AGR %)
Table 8.30 Medolac Laboratories Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.31 Medolac Laboratories SWOT Analysis 2018
Table 8.32 ZuChem Inc. Profile 2019 (CEO, Parent Company Sales US$m, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.33 Selected Recent ZuChem Inc. Human Milk Oligosaccharides (HMO) Market Developments 2015-2018 (Date, Strategy, Details)
Table 8.34 ZuChem Inc. Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.35 Glycosyn LLC Profile 2019 (CEO, Parent Company Sales US$m, Business Segment in the Market, HQ, Founded, No. of Employees, Website)
Table 8.36 Selected Recent Glycosyn LLC Human Milk Oligosaccharides (HMO) Market Developments 2016-2017 (Date, Strategy, Details)
Table 8.37 Glycosyn LLC Sales 2015-2018 (US$m, AGR %)
Table 8.38 Glycosyn LLC Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product)
Table 8.39 Gnubiotics Sciences Sarl Profile 2019 (CEO, Parent Company Sales US$m, Net Income, Business Segment in the Market, HQ, Founded, No. of employees, Website)
Table 8.40 Gnubiotics Sciences Sarl Key Developments (Date, Strategy, Details)
Table 8.41 Gnubiotics Sciences Sarl Sales 2014-2018 (US$m, AGR %)
Table 8.42 Gnubiotics Sciences Sarl Net Income / Loss 2014-2018 (US$ MN)
Table 8.43 Agrana Beteiligungs-AG Profile 2019 (CEO, Parent Company Sales US$m, Industry Group in the Market, HQ, No. of Employees, Website)
Table 8.44 Selected Recent Agrana Beteiligungs-AG Human Milk Oligosaccharides (HMO) Market Developments 2016-2018 (Date, Strategy, Details)
Table 8.45 Agrana Beteiligungs-AG Sales 2013-2017 (US$m, AGR %)
Table 8.46 Agrana Beteiligungs-AG Industry Group Revenue 2017 (US$Mn)
Table 8.47 Agrana Beteiligungs-AG Human Milk Oligosaccharides (HMO) Market Products / Services (Segment of Business, Product, Specification / Features)
Table 8.48 Agrana Beteiligungs-AG Top Ten Markets in target Product Types (Rank, Countries)
Table 8.49 Agrana Beteiligungs-AG Top Ten Markets in Processing Solutions (Rank, Countries)
Table 8.50 Agrana Beteiligungs-AG SWOT Analysis 2018
Table 8.51 Other Leading Companies in the Human Milk Oligosaccharides (HMO) Market Value Chain 2018 (S. No, Company)
Table 8.1 Global Human Milk Oligosaccharides (HMO) Market Summary 2019, 2024, 2029 ($m, CAGR%)
Table 8.2 Global Human Milk Oligosaccharides (HMO) Market Summary by Geography (2019)
Table 8.4 Global Human Milk Oligosaccharides (HMO) Market Summary by Product Type (2019, 2029)



★調査レポート[人乳オリゴ糖(HMO)の世界市場2019-2029] ( Human Milk Oligosaccharides (HMO) Market Report 2019-2029 / VGN910309) 販売に関する免責事項
[人乳オリゴ糖(HMO)の世界市場2019-2029] ( Human Milk Oligosaccharides (HMO) Market Report 2019-2029 / VGN910309) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆